News & Insights Client News News & Insights Client News C Street Works Weight Watchers Chapter 11 May 7, 2025 May 7, 2025 / O’Dwyer PR – WW International has filed for Chapter 11 as its Weight Watchers unit faces heavy competition from prescription weight-loss drugs and struggles under crushing debt. The financial reorganization will eliminate $1.5B debt from its balance sheet as it expands its robust tele-health operation. WW’s telehealth program is a “holistic model of care” that features access to obesity-trained clinicians, prescription weight-loss medication and virtual and in-person workshops. The Chapter 11 filing provides WW with the flexibility to accelerate innovation, reinvest in members and position for growth in the weight management landscape, according to Tara Comonte, WW CEO. As the focus on weight loss shifts to long-term health, Comonte said “our commitment to delivering the most trusted, science-backed, and holistic solutions—grounded in community support and lasting results—has never been stronger, or more important.” WW expects to emerge from Chapter 11 in 45 days, or sooner. The company reported a 9.7 percent decline in Q1 revenues to $186.6M and a $72.6M loss. ICR Inc. has John Mills and Anna Kate Heller handling the financial community, while C Street Advisory Group covers the strategic communications beat for WW. Share this article Featured Insights The Comeback Playbook: How Strategic Communications and Branding Drive Corporate Turnarounds Related Articles Dec 11, 2024 SEKO Logistics Closes Landmark Recapitalization Transaction and Announces New Leadership Appointments to Drive Next Era of Growth Strategic Recapitalization Strengthens Financial Foundation, Fostering Long-Term Stability and Industry Leadership New Executive Leadership Appointments... Read the Article Jan 8, 2025 Alacrity Solutions Agrees to Strategic Transaction for Long-Term Growth as a Leader in the Claims Management Industry Company Partners with Leading Investment Firms to Support Continued Growth and Investment in Innovation Operations... Read the Article Sep 5, 2025 Mosaic Receives Court Approval of Plan of Reorganization Company’s Existing Lender to Assume Loan Servicing, Operating as Solar Servicing LLC, Subsidiary of Forbright... Read the Article Mar 3, 2025 Alacrity Solutions Successfully Completes Strategic Transaction to Strengthen Financial Foundation for Continued Industry Leadership Company Receives $175 Million in New Capital to Invest in Growth and Technological Innovation Reinforces... Read the Article Aug 25, 2025 Ayrmid Ltd. Announces FDA Acceptance and Priority Review for Omidubicel for the Treatment of Severe Aplastic Anemia (SAA) FDA assigns Prescription Drug User Fee Act (PDUFA) target date of December 10, 2025 LONDON–(BUSINESS... Read the Article Sep 8, 2024 Hoonigan Announces Strategic Transaction to Strengthen Financial Foundation and Support Long-Term Growth Enters into Restructuring Support Agreement to Eliminate Approximately $1.2 Billion of Debt Files Voluntary Prepackaged... Read the Article
Dec 11, 2024 SEKO Logistics Closes Landmark Recapitalization Transaction and Announces New Leadership Appointments to Drive Next Era of Growth Strategic Recapitalization Strengthens Financial Foundation, Fostering Long-Term Stability and Industry Leadership New Executive Leadership Appointments... Read the Article
Jan 8, 2025 Alacrity Solutions Agrees to Strategic Transaction for Long-Term Growth as a Leader in the Claims Management Industry Company Partners with Leading Investment Firms to Support Continued Growth and Investment in Innovation Operations... Read the Article
Sep 5, 2025 Mosaic Receives Court Approval of Plan of Reorganization Company’s Existing Lender to Assume Loan Servicing, Operating as Solar Servicing LLC, Subsidiary of Forbright... Read the Article
Mar 3, 2025 Alacrity Solutions Successfully Completes Strategic Transaction to Strengthen Financial Foundation for Continued Industry Leadership Company Receives $175 Million in New Capital to Invest in Growth and Technological Innovation Reinforces... Read the Article
Aug 25, 2025 Ayrmid Ltd. Announces FDA Acceptance and Priority Review for Omidubicel for the Treatment of Severe Aplastic Anemia (SAA) FDA assigns Prescription Drug User Fee Act (PDUFA) target date of December 10, 2025 LONDON–(BUSINESS... Read the Article
Sep 8, 2024 Hoonigan Announces Strategic Transaction to Strengthen Financial Foundation and Support Long-Term Growth Enters into Restructuring Support Agreement to Eliminate Approximately $1.2 Billion of Debt Files Voluntary Prepackaged... Read the Article